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Abstract
Capnocytophaga canimorsus is a usual member of dog’s mouths flora that causes rare but dramatic human infections after
dog bites. We determined the structure of C. canimorsus lipid A. The main features are that it is penta-acylated and
composed of a ‘‘hybrid backbone’’ lacking the 49 phosphate and having a 1 phosphoethanolamine (P-Etn) at 2-amino-2-
deoxy-D-glucose (GlcN). C. canimorsus LPS was 100 fold less endotoxic than Escherichia coli LPS. Surprisingly, C. canimorsus
lipid A was 20,000 fold less endotoxic than the C. canimorsus lipid A-core. This represents the first example in which the
core-oligosaccharide dramatically increases endotoxicity of a low endotoxic lipid A. The binding to human myeloid
differentiation factor 2 (MD-2) was dramatically increased upon presence of the LPS core on the lipid A, explaining the
difference in endotoxicity. Interaction of MD-2, cluster of differentiation antigen 14 (CD14) or LPS-binding protein (LBP) with
the negative charge in the 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) of the core might be needed to form the MD-2 – lipid
A complex in case the 49 phosphate is not present.
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Introduction
Capnocytophaga canimorsus, a usual member of dog’s mouths flora
[1] was discovered in 1976 [2] in patients who underwent
dramatic infections after having been bitten, scratched or simply
licked by a dog. The most common syndrome is sepsis, sometimes
accompanied by peripheral intravascular coagulation and septic
shock [3]. C. canimorsus is a Gram-negative rod belonging to the
family of Flavobacteriaceae in the phylum Bacteroidetes [4,5]. Human
infections occur, worldwide, with an approximate frequency of
one per million inhabitants per year [6].
C. canimorsus are able to escape complement killing and
phagocytosis by human polymorphonuclear leukocytes and
macrophages [7,8]. Whole bacteria are also poor agonists of
Toll-like receptor (TLR) 4, which results in a lack of release of pro-
inflammatory cytokines by macrophages [9]. In addition to these
‘‘passive’’ features, C. canimorsus have been shown to harvest glycan
moieties from glycoproteins at the surface of animal cells,
including phagocytes [10,11,12], in addition they also deglycosy-
late human IgG [12].
One of the most pro-inflammatory bacterial compounds is the
lipopolysaccharide (LPS, endotoxin) [13], consisting of three
domains: lipid A, the core-oligosaccharide and the O-polysaccha-
ride (O-antigen). As a potent activator of the innate immune
system, LPS can induce endotoxic shock in patients suffering from
septicemia. Recognition of LPS by the host occurs via the TLR4/
MD-2/CD14 receptor complex [14,15,16], at which two proteins,
CD14 and LBP, have been shown to enhance the response to LPS
by transporting single LPS molecules [17,18,19,20]. It has been
shown that the lipid A moiety of the LPS is sufficient for TLR4
binding and stimulation [21,22]. The interaction of lipid A and its
receptor was unraveled by x-ray crystallography pioneering studies
of complexes between MD-2 and the lipid A analog Eritoran [23]
or lipid IVA [24]. The identification of the binding sites of lipid A
to MD-2 and also to the Leucine-rich repeat (LRR)-domains of
TLR4 [21] is a landmark achievement that enables a deeper
understanding of the structure-function relationship between LPS/
lipid A and its receptors. According to these data, the 1 and 49
phosphates of the lipid A backbone, which form charge
interactions with TLR4 and MD-2, are the key elements for
receptor activation [21,25], even though for some of the
interactions conflicting data have been reported [26]. It was
further shown that the b-hydroxymyristate chain at position 2
forms hydrogen bonds and hydrophobic interactions with TLR4.
At present, there is no evidence that the LPS-core plays any major
role in binding to TLR4; only a 10- to 100-fold difference in
endotoxicity of lipid A and LPS has been reported for E. coli,
Porphyromonas gingivalis or Proteus mirabilis [27,28], but these small
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differences have been attributed to changes in solubility, even if
solid experimental proof is lacking. The core-oligosaccharide has
so far never been shown to alter TLR4/MD-2 binding of a specific
lipid A, only slight changes in MD-2 binding have been reported
[29].
In this work, we investigated the lipid A structure of C. canimorsus
in order to clarify its contribution to the septicemia and shock
provoked by these bacteria. Very few lipid A structures have
actually been solved in the Cytophaga/Flavobacterium group, with the
exception of the lipid A from Elizabethkingia meningoseptica (former
Flavobacterium meningosepticum) [30]. Already some time ago, the acyl
chains present in the LPS of Cytophaga bacteria have been
identified as [13-Me-14:0 (i15:0), 13-Me-14:0(3-OH)(i15:0(3-
OH), 16:0(3-OH) and 15-Me-16:0(3-OH) (i17:0(3-OH)] [31],
whereat i15:0 is iso-pentadecanoic acid (13-methyltetradecanoic
acid, 13Me-14:0), i15:0(3-OH) represents iso-(R)-3-hydroxypenta-
decanoic acid [(R)-3-hydroxy-13-methyltetradecanoic acid, 13Me-
14:0(3-OH)]; 16:0(3-OH) is (R)-3-hydroxyhexadecanoic acid and
i17:0(3-OH) represents iso-(R)-3-hydroxyheptanoic acid [(R)-3-
hydroxy-15-methylhexanoic acid, 15-Me-16:0(3-OH)]. Here we
show that lipid A of C. canimorsus consists of the penta-acylated
hybrid backbone 2,3-diamino-2,3-dideoxy-D-glucose (b-D-
GlcN3N9) linked (19R6) to a-D-GlcN where the 49 phosphate
group is missing and the 1 phosphate is linked to an ethanolamine
group, forming a P-Etn. Not unexpectedly, this lipid A was of very
low endotoxicity but, surprisingly, when bound to the core [lipid
A-core (LA-core)] it became 20,000 fold more endotoxic. In
agreement with this observation, we show that the LPS core
promotes the binding of C. canimorsus lipid A to MD-2. This is the
first example of a core-oligosaccharide dramatically changing the
endotoxicity of lipid A, in which the carboxy group of Kdo
probably takes over the function of ionic binding of the missing 49
phosphate in the lipid A.
Results
Compositional analyses of lipid A
GlcN and GlcN3N were found in a ratio of approx. 2:1
(Table 1). Based on the notion that by gas-liquid chromatography
(GLC) analysis synthetic GlcN3N expressed a response factor of
about 50% when compared with GlcN (or Galactosamine (GalN)
as internal standard), it was inferred that GlcN and GlcN3N are
present in equimolar amounts in the lipid A backbone, suggesting
the presence of a ‘‘hybrid backbone’’ in C. canimorsus lipid A
(Table 1). Total fatty acid analysis revealed i15:0, i15:0(3-OH),
16:0(3-OH), and i17:0(3-OH) in a molar ratio of approximately
1:1:1:2 in lipid A preparations. Analysis of ester-bound acyl chains
indicated the presence of i15:0 and i15:0(3-OH) in approximately
equimolar amounts, indicating that one 16:0(3-OH) and two
i17:0(3-OH) residues are primary acyl chains N-linked to the lipid
A backbone (Table 1). This result suggests a penta-acylated lipid A
species.
High-performance liquid chromatography (HPLC) and
mass spectrometry (MS) analyses of lipid A
The reversed phase HPLC profile of the lipid A sample is shown
in Fig. S1. Peak 2 expressed a molecular ion at m/z 1716.30,
which is in excellent agreement with a lipid A containing i15:0,
i15:0(3-OH), 16:0(3-OH), and two moles of i17:0(3-OH) attached
to the lipid A backbone (GlcN3N-GlcN), which also carries one P-
Etn residue. The second major fraction (peak 5) at m/z 1594.29
was compatible with lipid A lacking the P-Etn. Based on peak
intensities (peaks 2 and 5) about 40% of the P-Etn was liberated,
most likely from the lipid A under the hydrolysis conditions used
(Fig. S1).
All lipid A fractions investigated expressed a certain heteroge-
neity with respect the chain length of acyl chains (-CH2- groups),
as all MS showed peak ‘‘clusters’’ differing by 14 u, thus suggesting
acyl chain heterogeneity (Table 2, Fig. S2). Combined GLC/mass
spectrometry (GLC-MS) analysis of the acyl chains revealed that
the mass difference of Dm/z= 14 u was not due to the exchange of
one single, prominent shorter acyl chain [e.g. 16:0(3-
OH)Ri15:0(3-OH)]. Instead, the lipid A showed a certain
structural ‘‘fuzziness’’ with respect to the size and position of the
individual acyl chains, which, according to this finding, appeared
Table 1. Compositional analysis data of the purified lipid A of
C. canimorsus 5 wild type.
Component nmol/mg mol/mol GlcN
Sugars
GlcN3Na,c,* 167 0.5
GlcNa,c 358 1.0
Polar substituents
Pb 468 1.3
Etn-Pc ND -
Etnc ND -
Fatty acidsa
i15:0 278 0.8
i15:0(3-OH) 416 1.2
16:0(3-OH) 417 1.2
i17:0(3-OH) 709 2.0
aGLC-MS data,
bPhotometric assay,
cHPLC (Pico-tag).
*Per-O-acetylated GlcN3N-ol can only be quantified by GLC analysis by approx.
50% compared to GlcNAc-ol, as determined by synthetic reference compound.
doi:10.1371/journal.ppat.1002667.t001
Author Summary
Capnocytophaga canimorsus, a commensal bacterium in
dog’s mouths, causes rare but dramatic infections in
humans that have been bitten by dogs. The disease often
begins with mild symptoms but progresses to severe
septicemia. The lipopolysaccharide (LPS), composed of
lipid A, core and O-antigen, is one of the most pro-
inflammatory bacterial compounds. The activity of the LPS
has so far been attributed to the lipid A moiety. We
present here the structure of C. canimorsus lipid A, which
shows several features typical for low-inflammatory lipid A.
Surprisingly, this lipid A, when attached to the core-
oligosaccharide was far more pro-inflammatory than lipid
A alone, indicating that in this case the core-oligosaccha-
ride is able to contribute significantly to endotoxicity. Our
further work suggests that a negative charge in the LPS-
core can compensate the lack of such a charge in the lipid
A and that this charge is needed not for stabilization of the
final complex with its receptor but in the process of
forming it. Overall the properties of the lipid A-core may
explain how this bacterium first escapes the innate
immune system, but nevertheless can cause a shock at
the septic stage.
C. canimorsus Lipid A Structure and Function
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to be statistically distributed over all positions with no specific
structural variation.
The ESI-MS data of the wt strain shown in Table 2 indicated
identical mass at m/z 1716.30 for peaks 2 and 3. As these lipid A
fractions differed in their retention time, we conclude that they
represent different structural isomers as they could be baseline-
separated by HPLC. This HPLC analysis in combination with
ESI-MS data thus shows that structural heterogeneity might not
be solely related to the chain length of one acyl chain, but also to
its position within the lipid A backbone.
In order to allocate the type of the hybrid lipid A backbone, the
acyl chain distribution over the lipid A backbone, and the
attachment side of the P-Etn, electrospray-ionization Fourier
transform ion-cyclotron resonance (ESI FT-ICR) MS/MS in the
positive mode was run [32]. The triethylammonium salt of HPLC
purified lipid A at m/z 1820.40 was selected as precursor ion (Fig.
S3). Infrared multiphoton dissociation (IRMPD)-MS/MS gener-
ated one abundant characteristic B-fragment oxonium-ion of the
non-reducing end at m/z 907.77, which is in excellent agreement
with the mass value calculated for GlcN3N with i15:0, 16:0(3-
OH), and i17:0(3-OH) attached (m/z 907.77). This fragmentation
pattern also showed that P-Etn is attached at the reducing end -
most likely at position C-1. Thus the lipid A in C. canimorsus is
penta-acylated with an acylation pattern of three being attached to
the ‘‘non-reducing’’ GlcN3N9 and two to the reducing GlcN sugar
(3+2) in the lipid A hybrid backbone.
Nuclear magnetic resonance (NMR) analysis of lipid A
The lipid A was studied further by high-field NMR spectros-
copy using correlation spectroscopy (COSY), total correlation
spectroscopy (TOCSY), rotating-frame nuclear Overhauser effect
spectroscopy (ROESY), 1H,13C-heteronuclear single-quantum
coherence (HSQC), 1H,31P-heteronuclear multiple-quantum co-
herence (HMQC), and 1H,31P-HMQC-TOCSY experiments.
The results are depicted in the supplement (Table S1). The
1H,13C-HSQC spectrum (Fig. 1) showed two H-1,C-1 cross-peaks
at d 4.28/103.4 and 5.29/92.8 for GlcN3N9 and GlcN, which
were distinguished by correlations between protons at nitrogen-
bearing carbons and the corresponding carbons (C-29 and C-39 of
GlcN3N9 and C-2 of GlcN, at d 52.9, 54.6, and 51.4, respectively).
3J1,2 coupling constants of 8.0 and 2.9 Hz for the H-1 signals at d
4.28 and 5.29, were determined from the 1H NMR spectrum and
showed that GlcN3N is b- and GlcN a-linked. The H-1 signal of
a-GlcN was additionally split due to coupling to phosphorus (2J1,P
7.9 Hz), thus indicating that a-GlcN is phosphorylated with P-Etn
and b-GlcN3N9 represents the ‘‘non-reducing’’ end of the lipid A
backbone. The b19R6-linkage between the two amino sugars was
evident from strong cross-peaks of H-19 of GlcN3N9 with protons
H-6a9,6b9 of GlcN at d 3.64 and 3.87 in the ROESY spectrum.
The location of the P-Etn residue at position 1 of a-GlcN was
further confirmed by 1H,31P-HMQC and 1H,31P-HMQC-
TOCSY (Fig. S4) as well as ROESY experiments, which showed
correlations between H-1 of GlcN at d 5.29 and H-1a,1b of
ethanolamine (Etn) at d 3.91 and 3.98. In accordance with the
19R6 linkage and the position of GlcN3N at the ‘‘non-reducing
end’’, the 13C NMR spectrum (Table S1) displayed a typical
down-field displacement by ,10 ppm for C-6 of the 6-substituted
GlcN (d 71.0; compared with d 60.0 for C-6 of GlcN3N9, which is
non-substituted in the free lipid A). The acylation pattern was
confirmed by 1H,13C-HSQC spectroscopy (Fig. 1), which showed
only one characteristic downfield shift due to a deshielding effect
for the i17:0[3-O(i15:0)] R29 i.e. the H-3/C-3 R29 cross-peak at d
4.95/70.7. This finding indicated that only the OH-group of i17-
0(3-OH) is acylated giving rise to an acyloxyacyl residue [i17:0-3-
O(i15:0)] showing a 3+2 type acyl chain distribution in the penta-
acylated lipid A, which is in good agreement with the MS data
(Figs. S2 and S3). Taking together the data of the chemical studies
defines the structure of the lipid A of C. canimorsus shown in Fig. 2
A. The structure of E. coli hexa-acylated lipid A is depicted for
comparison (Fig. 2 B). The E. coli lipid A consists of a b-(19R6)-
linked GlcN disaccharide that is phosphorylated at positions 1 and
49 and carries four (R)-3-hydroxymyristate chains (at positions 29,
39, 2 and 3). The R29 and R39 3-hydroxylated acyl groups in
GlcN9 are further esterified with laurate and myristate, respec-
tively [22].
C. canimorsus LPS core features only one Kdo
The structure of C. canimorsus LA-core is depicted in Fig. 2 C
and its structural analysis will be described elsewhere (Za¨hringer et
al., manuscript in preparation). The C. canimorsus LPS core features
only one Kdo, to which a P-Etn is attached in position 4. Usually,
mono-Kdo LPS-core have a phosphate attached to the Kdo at that
position. Thus, the only net negative charge in this core
oligosaccharide originates from the carboxy-group of the Kdo.
The inner core continues with two mannoses (Man) to which
another P-Etn is attached in position 6 of ManI residue in the core
oligosaccharide. The outer core consists of Galactose (Gal) and L-
Rhamnose (to which the O-antigen is attached). A positively
Table 2. ESI-MS analysis of lipid A fractions obtained by reversed phase HPLC shown in Fig. S1.
Peak No. Retention time in min Yield in mg (%) Mol. Mass of the major peak
1a 118.5 0.13 (5.8) 1660.235
1b 119.7 0.18 (8.3) 1674.265
2 124.3 0.66 (25.5) 1716.300
3 127.3 0.06 (2.8) 1716.301
5 131.9 0.55 (24.2) 1594.292
6 ,133 0.19 (8.8) 1608.306
69 134.6 0.09 (4) 1589.266
69 1594.290
Applied: 2.1 mg
Total yield: 1.86 mg (88.6%)
The major peaks shown in bold at m/z 1716.30 (peak 2) and m/z 1594.29 (peak 5) represent the lipid A and the lipid A lacking the P-Etn group at C-1 of GlcN.
doi:10.1371/journal.ppat.1002667.t002
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charged Galactosamine (GalN) residue is linked to the (second)
ManII residue in position 6 (U. Za¨hringer, unpublished results).
The structure identified matches the C. canimorsus
genome
E. coli lipid A biosynthesis has been unravelled in detail [22,33].
Analyzing the genome of C. canimorsus 5 [5], we identified the
genes required for the synthesis of lipid A-Kdo [33]. Only lpxA,
lpxA9, lpxC and lpxD seem to cluster in one operon, the other genes
are dispersed (Fig. 3 A). The difference in acylation of the 39 and 3
position and the hybrid backbone of the lipid A consisting of a b-
19,6-linked GlcN3N9-GlcN disaccharide, suggests that two lpxA
genes might be present in C. canimorsus and indeed two lpxA genes
were identified (termed lpxA and lpxA9) in the C. canimorsus 5
genome (Fig. 3 A). In Acidithiobacillus ferrooxidans GnnA and GnnB
are responsible for the biosynthesis of GlcN3N [34]. Based on the
sequences of A. ferrooxidans, gnnA and gnnB could be identified in the
genome of C. canimorsus (Fig. 3 A). In the biosynthetic pathway of
E. coli lipid A, enzyme LpxM adds the acyloxyacyl-residue [14:0-3-
O(14:0)] representing the 6th acyl chain [22]. In good agreement
with the penta-acylation of lipid A in C. canimorsus 5 was our
finding that lpxM could not be identified in the genome (Fig. 3 A).
C. canimorsus LPS core features only one Kdo, suggesting a mono-
functional Kdo transferase (WaaA/KdtA) or a Kdo hydrolase two-
protein complex (KdoH1/2) as in Helicobacter pylori or Francisella
novicida [35,36]. Searches with KdoH1/2 did not hit any gene in
the C. canimorsus 5 genome. Therefore, C. canimorsus possesses either
a mono-functional WaaA or a KdoH1/2 complex without
significant sequence similarity to known Kdo hydrolases. We have
further investigated the enzymes leading to the addition of an Etn
at the 1 phosphate of lipid A. In H. pylori, the addition of a P-Etn at
1 position has been proposed to result from a two-step mechanism
[37]. In a first step the 1 phosphate is removed by a phosphatase
(LpxE), and subsequently a P-Etn-transferase (EptA or PmrC,
YjdB) adds a P-Etn to the 1 position of lipid A [37] (Fig. 3 B). In H.
pylori lpxE and eptA are encoded by one operon (Hp0021-Hp0022).
C. canimorsus eptA was annotated as Ccan 16950. Search for a lipid A
phosphatase were based on lpxE and/or lpxF sequences from P.
gingivalis [38], F. novicida [39], Rhizobium etli [40] H. pylori [37,41]
and on all available Bacteroidetes-group pgpB sequences. Three lpxE/
F candidates have been found in the C. canimorsus 5 genome
(Ccan16960, Ccan14540 and Ccan6070). All candidates were deleted
and the mutated bacteria were tested for endotoxicity. Only
deletion of Ccan16960 affected endotoxicity (data not shown).
Figure 1. NMR analysis of the lipid A from C. canimorsus wild type. 1H,13C-HSQC spectrum (700 MHz) of lipid A in chloroform-methanol-water
(20:10:1, v/v/v) at 27uC. The corresponding parts of the 13C and 1H NMR spectra are displayed along the F1 and F2 axes, respectively. Numerals refer
to atoms in sugar and acyl chain residues denoted by letters as shown in Supplementary Table 1 and Fig. S2. Signals from an unidentified
contaminating lipid are indicated by X.
doi:10.1371/journal.ppat.1002667.g001
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Figure 2. Structures of C. canimorsus lipid A, E. coli lipid A and core-oligosaccharide of C. canimorsus attached to the lipid A. (A) C.
canimorsus lipid A consists of a b-(19R6)-linked GlcN3N9-GlcN disaccharide, to which 3-hydroxy-15-methylhexadecanoic acid, 3-hydroxy-13-
methyltetradecanoic acid, 3-O-(13-methyltetradecanoyl)-15-methylhexadecanoic acid, and 3-hydroxyhexadecanoic acid are attached at positions 2, 3,
29, and 39, respectively. The disscharide carries a positively charged ethanolamine at the 1 phosphate and lacks a 49 phosphate. (B) Structure of E. coli
hexa-acylated lipid A. (C) C. canimorsus LPS core features only one Kdo, to which a phosphoethanolamine (P-Etn) is attached. The only net negative
charge present is from the carboxy group of the Kdo. The inner core continues with Man to which another a P-Etn is attached. The outer core consists
of Gal and L-Rhamnose (L-Rha), to which the O-antigen is attached (U. Za¨hringer, unpublished results).
doi:10.1371/journal.ppat.1002667.g002
C. canimorsus Lipid A Structure and Function
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Interestingly, Ccan16960 is located within the same operon as eptA
and the two genes overlap by 20 bp. Following the operon
organisation of H. pylori, Ccan16960 has been annotated as lpxE.
The predicted function of lpxE and eptA was validated by KO and
analysis of the resulting phenotype (Ittig et al., manuscript in
preparation).
The presence of the 49 kinase LpxK and the absence of a 49
phosphate leads to the assumption of the presence of a 49
phosphatase, LpxF. Several candidate genes were identified
(besides lpxE: Ccan 14540 and Ccan6070) and deleted but they
had to be ruled out, as no deletion did affect the endotoxic activity
(data not shown), thus, we lack annotation of lpxF. The proposed
complete biosynthesis of C. canimorsus lipid A-Kdo is depicted in
Fig. 3 C, starting from UDP-N-acetyl-D-glucosamine and ribulose-
5 phosphate.
C. canimorsus LPS is 100-fold less endotoxic than E. coli
O111 LPS
The endotoxic activity of wt C. canimorsus 5 LPS (S-form) was
compared to the endotoxic activity of E. coli O111 LPS using three
different approaches: (i) Purified LPS samples were assayed for
TLR4 dependent NFkB activation with HEK293 cells overex-
pressing human TLR4/MD-2/CD14 and a secreted reporter
protein (HEKBlue human TLR4 cell line), (ii) purified LPS
samples were assayed for induction of TNFa release by human
THP-1 macrophages, (iii) purified LPS samples were tested for
stimulation of IL-6 release by canine DH82 macrophages. In the
two assays involving human TLR4 (Fig. 4 A and Fig. 4 C) C.
canimorsus LPS appeared to be about 100 fold less endotoxic than
E. coli O111 LPS (both S-form LPS). In contrast to human
macrophages, where C. canimorsus LPS was found 10–100 fold less
endotoxic than E. coli O111 LPS (Fig. 4 B), for canine
macrophages the difference in endotoxicity of the two LPS was
around 1000 fold (Fig. 4 E). In addition, lipid IVA seems not to be
an agonist of canine TLR4 as is the case for murine TLR4 [42].
C. canimorsus lipid A and LA-core exhibit striking
difference in endotoxicity
Generally, the lipid A part of a LPS is considered as sufficient to
trigger full TLR4 activation. Minor differences between lipid A
and LPS or LA-core have so far been attributed to differential
bioavailability/solubility in water even if solid experimental proof
is lacking. We have, therefore, examined the endotoxic activity of
C. canimorsus lipid A, LA-core and LPS using the HEKBlue hTLR4
Figure 3. Biosynthesis of C. canimorsus lipid A-Kdo. (A) Alphabetic list of enzymes required and the corresponding gene codes in the C.
canimorsus 5 genome are listed. (B) Proposed enzymatic modification on lipid A by LpxF, LpxE and EptA. (C) Single steps in the biosynthesis of C.
canimorsus lipid A-Kdo (adapted from KEGG map00540).
doi:10.1371/journal.ppat.1002667.g003
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cell line and the TNFa release by human THP-1 macrophages.
LPS and LA-core exhibited an endotoxicity in the same range,
whereas the LPS was less than 10-fold more endotoxic than the
LA-core (Fig. 4 B and Fig. 4 D). In contrast, C. canimorsus lipid A
appeared to be absolutely non-stimulatory up to 5 mg/ml (Fig. 4 B
and Fig. 4 D), around 20,000-fold less active than the LA-core and
200,000-fold less active than LPS on a weight basis (ng/ml)
indicating a even higher difference on a molar basis. As the C.
canimorsus LPS and the LA-core showed similar endotoxicity, the
increase in endotoxicity in comparison to the lipid A must have
been raised by the contribution of the core oligosaccharide. Minor
differences in endotoxicity between LPS and LA-core as the 10- to
100-fold difference observed between E. coli lipid A and E. coli
O111 LPS (Fig. 4 B and Fig. 4 D) might be explained by
differential bioavailability/solubility in water/buffer and by a
direct contribution of the core-oligosaccharide in TLR4/MD-2
binding as suggested [21]. However, in the case of C. canimorsus
LA-core the direct contribution of the core-oligosaccharide might
be far more pronounced as in E. coli, since C. canimorsus has a lipid
A lacking a net negative charge. A role of the core-oligosaccharide
in providing solubility to lipid A was ruled out by the fact that no
increase in endotoxicity was observed by the addition of
triethylamine (TEN) or dimethyl sulfoxide (DMSO) to the C.
canimorsus lipid A stock solution followed by sonication (see Fig. 4
F).
C. canimorsus LPS core is essential for proper MD-2
binding of the lipid A
The increase in endotoxicity of the C. canimorsus LA-core in
comparison to the lipid A must have been raised by the
contribution of the core oligosaccharide (Fig. 4). The 49 phosphate
of E. coli lipid A is known to interact with Arg264 and Lys362 of
TLR4 and Lys58 and Ser118 of MD-2 [21]. C. canimorsus lipid A
lacks the 49 phosphate and features only one net negative charge in
the LPS core, namely the carboxylic oxygen of Kdo. Based on the
known structure of E. coli LPS bound to TLR4/MD-2 (3FXI, [21])
we measured the interaction distances from the carboxylic oxygen
of Kdo to Arg264 and Lys362 of TLR4 and to Lys58 and Ser118 of
MD-2. The carboxylic oxygen of Kdo is within close distance to
Arg264 and Lys362 of TLR4 and Lys58 and Ser118 of MD-2 and
hence could contribute to binding to MD-2 or TLR4.
To assess the ability of C. canimorsus lipid A or LA-core to
interact with human MD-2, we monitored their ability to compete
with the binding of E. coli LPS-Biotin to MD-2. Culture
supernatants of cells producing human MD-2 were incubated
with biotinylated E. coli O111 LPS, either alone or in combination
with different concentrations of a competitor. As a source of LBP
and soluble CD14, 7.5% FCS (v/v) was added. After purification
of LPS based on biotin, co-purification of MD-2 was monitored by
Western blotting. C. canimorsus LA-core abolished the copurifica-
tion of MD-2 with the E. coli LPS-Biotin at higher concentration
than the positive controls, E. coli O111 LPS and lipid IVA but at
lower concentration than unbiotinylated E. coli penta-acyl lipid A
(Fig. 5 A and B). Lipid IVA is expected to be a very potent
competitor, as it has been shown to bind deeper into the MD-2
pocket and thus likely stronger to MD-2 than E. coli lipid A
[21,24]. These results indicate that C. canimorsus LA-core binds to
human MD-2, likely in the same pocket as E. coli LPS. This
experiment does not reflect the antagonistic capacity of C.
canimorsus LA-core as even native E. coli O111 LPS could prevent
the co-purification of human MD-2 (Fig. 5 A and B). In contrast to
the LA-core, C. canimorsus lipid A did not significantly affect the
copurification of MD-2 with E. coli LPS-Biotin even at high
concentration (Fig. 5 A and B). Thus, C. canimorsus lipid A seems
not to bind to human MD-2 at all or to bind to MD-2 only very
weakly, in contrast to the LA-core. To rule out a major
contribution of the core-oligosaccharide by providing solubility
to the lipid A, the same MD-2 binding experiment has been
performed with C. canimorsus lipid A pre-treated with DMSO or
TEN and sonicated to improve solubility. These C. canimorsus lipid
A samples did not significantly affect the copurification of MD-2
with E. coli LPS-Biotin even at high concentration (Fig. 5 C). We
conclude from this experiment that the C. canimorsus LPS core
promotes the interaction and binding of the lipid A to MD-2 either
via direct interaction with MD-2 or via binding to LBP or CD14.
The final complex of human MD-2 and lipid A of C.
canimorsus would be as stable as MD-2 and lipid A of E.
coli
In order to assess the contribution of the C. canimorsus LPS core
in binding of the lipid A to MD-2, we modelled the binding of C.
canimorsus lipid A to human MD-2 (Fig. 6 A) and compared it to
the binding of E. coli lipid A. Some differences between the two
complexes could be observed at the level of the lipid chains after
just few ns of simulation (Fig. 6 A). In both cases the R39 and R3
chains (see Fig. 2 for nomenclature) were fully stretched and
interacted with the same residues. No empty space was left by R30
(missing in C. canimorsus) because the longer R29 and R20 chains
filled the void. While in E. coli the R2 chain is stretched toward the
inner side of the pocket, in C. canimorsus it was projected toward the
pocket exterior, due to both i) its longer size and ii) to the presence
of the bifurcated terminus of the close R20. The R2 chain of C.
canimorsus lipid A was thus not completely buried inside the MD-2
pocket and it was even more exposed to the surface than the
hydroxymyristate chain at position 2 in E. coli. This probably
enables the i17:0(3-OH) chain at position 2 to interact with TLR4,
as has been reported for the R2 chain of hexa-acylated E. coli LPS
[21]. It should be mentioned here that penta-acylated E. coli lipid
A is endotoxically almost inactive [13], and the acyl chains might
be completely buried inside MD-2. Thus C. canimorsus penta-
acylated lipid A is expected to behave differently from penta-
acylated E. coli lipid A due to the extended length of the acyl
chains and the bulky iso-groups. Overall the arrangement of the
sugar moieties with respect to the MD-2 was similar for both
complexes, the only major discrepancies being the orientation of
the 1-phosphoryl group (1 phosphate in E. coli, 1 P-Etn in C.
canimorsus). The calculated binding energy for the two complexes
was very similar when calculated at both MM-GBSA (molecular
Figure 4. Endotoxic activity of C. canimorsus (Cc) LPS, lipid A (LA) or lipid A-core (LA-core) and contribution of the LPS core to
endotoxicity. (A–B) Dose-response curve of purified lipid A, LA-core or LPS. Samples were assayed for TLR4 dependent NFkB activation with
HEKBlue human TLR4 cells. (C–D) Purified lipid A, LA-core or LPS samples were assayed for induction of TNFa release by human THP-1 macrophages.
(E) Purified LPS samples or lipid IVA were assayed for induction of IL-6 release by canine DH82 macrophages. (F) Dose-response curve of NFkB
activation by lipid A or LPS. Purified lipid A or LPS samples were assayed for TLR4-dependent NFkB activation with HEKBlue human TLR4 cells. The C.
canimorsus lipid A stock solution was pretreated with either 0.1% TEN or 50% DMSO and sonication to increase its solubility in water/buffer. Identical
concentrations of DMSO or TEN were added to E. coli O111 LPS as a control. Data were combined from n= 3 independent experiments, error bars
indicated are standard error of the mean.
doi:10.1371/journal.ppat.1002667.g004
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mechanics, the generalized Born model and solvent accessibility)
and MM-PBSA (molecular mechanics, Poisson-Boltzmann solvent
accessible surface area) level, being in both cases the MD-2 – E. coli
lipid A complex slightly more stable (Fig. 6 C). To understand this
trend the total binding free energy was fractionated into a list of
interaction energies between each residue of MD-2 and each
fragment of lipid A (Fig. 6 B), as coded in Fig. 2. Each pairwise
binding free energy value has been further fractioned into its
electrostatic, steric (Van der Waals), and solvation (polar and
cavitation) components. For each term contributions arising from
backbone and sidechain have been singled out. In both cases the
GlcN9 (E. coli) or the GlcN3N9 (C. canimorsus) moieties (29 NH
group) interacted with the backbone carbonyl of Ser120 establish-
ing a strong (about 4–5 kcal/mol) and persistent interaction.
Favorable interactions were also observed between GlcN and
residues Phe121 and Lys122. The side chain of Phe121 established a
strong apolar interaction (Van der Waals, non-polar solvation)
with the extended R3 acyl chain in both complexes. The hydrogen
bond between the NH group of Ser120 and the carbonyl of the R39
chain was found to be strong and persistent in both cases. Neither
the 1 phosphate group (E. coli) nor the 1 P-Etn (C. canimorsus)
established favorable interactions with MD-2, whereas the 49
phosphate group (missing in C. canimorsus) could be accounted for
the slightly greater stability of the MD-2 E. coli lipid A complex,
due to the strong (about 7.5 kcal/mol) interaction established with
both the backbone and the sidechain of Ser118 (see Fig. 6 B). In
summary, we found that in the final complex the arrangement of
the sugar moieties with respect to the MD-2 and the calculated
binding energy for the two complexes was very similar for E. coli
lipid A and C. canimorsus lipid A.
C. canimorsus lipid A is no antagonist of TLR4
C. canimorsus LPS, lipid A or LA-core were further tested for a
possible antagonistic activity on the action of E. coli O111 LPS
using HEKBlue human TLR4 cells. The cells were preincubated
for 3 h with various concentrations of purified C. canimorsus lipid A,
Figure 5. Binding to human MD-2 of C. canimorsus lipid A depends on the core-oligosaccharide. Soluble human MD-2 from cell culture
supernatant was combined with the indicated mixture of E. coli LPS-Biotin and a competitor (either C. canimorsus lipid A, lipid A-core, E. coli O111 LPS,
penta-acyl E. coli lipid A or lipid IVA). Biotinylated E. coli LPS-MD-2 complexes were purified and analyzed by non-reducing, denaturing Western
blotting for presence of MD-2. (A) Untreated human MD-2 did not bind to the Strep-column (lane 1), addition of E. coli LPS-biotin lead to co-
purification of human MD-2 (lane 2). Results shown are representative of three independent determinations. (B) Quantification of Western-blots as
shown in A. Values are shown as percentage of the corresponding positive control. Data were combined from n=3 independent experiments, error
bars indicated are standard error of the mean. (C) as in (A) but the C. canimorsus lipid A stock solution was pretreated with either 0.1% TEN or 50%
DMSO and sonication in both cases to increase its solubility in water/buffer.
doi:10.1371/journal.ppat.1002667.g005
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LA-core or LPS samples, then stimulated with 5 ng/ml E. coli
O111 LPS for further 20–24 h and the TLR4 dependent NFkB
activation was measured. C. canimorsus LPS, LA-core and lipid A
appeared to be no antagonist of E. coli O111 LPS binding to
human TLR4, in contrast to the tetra-acylated antagonist lipid
IVA (Fig. 7 A and B). In a second assay, human THP-1
macrophages were preincubated for 3 h with purified C. canimorsus
lipid A, LA-core or LPS samples at the concentration indicated.
Then the THP-1 cells were stimulated with 1 ng/ml E. coli O111
LPS for further 20 h and TNFa release was measured. C.
canimorsus lipid A exhibited no antagonism to E. coli O111 LPS
binding to human TLR4 (Fig. 7 D). Again lipid IVA showed the
expected antagonism (Fig. 7 C and D). Dependent on the assay no
antagonism or a very weak antagonism of C. canimorsus LPS was
observed. This is in agreement with the notion of a partial agonist
[43], which includes a certain degree of antagonism at sub-agonist
concentration.
All tested lipid A and LA-core fractions exhibited no activity
towards human TLR2, as tested by HEK293 cells overexpressing
human TLR2/MD-2 and a secreted reporter (Fig. S5). This
proves that the stimulation of HEKBlue human TLR4 cells with
C. canimorsus lipid A-core observed is only due to activation of
TLR4.
Discussion
We showed here that C. canimorsus has a penta-acylated lipid A,
a feature often correlated to low endotoxicity [13,25]. In addition,
the ester-bound 49 phosphate is lacking. This structural feature is
known to reduce the endotoxic activity by a factor of ,100 [13],
Figure 6. Modeled binding of C. canimorsus lipid A to human MD-2. (A) Front and side view of the equilibrated complexes between MD-2
(gray) and C. canimorsus (yellow) and E. coli (green) lipid A. (B) Pairwise decomposition of the global total (Van der Waals+electrostatic+solvation)
binding free energy calculated at MM-GBSA level. (C) Binding energy between MD-2 and the two lipid A molecules calculated using the MM-GBSA
and MM-PBSA methods on 300 snapshots extracted from two 10 ns long equilibrated NPT molecular dynamics simulations.
doi:10.1371/journal.ppat.1002667.g006
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Figure 7. Antagonistic activity of C. canimorsus (Cc) LPS, lipid A (LA) or LA-core on the action of E. coli O111 LPS. (A–B) HEKBlue human
TLR4 cells were preincubated for 3 h with purified lipid A, LA-core or LPS samples at the concentration indicated. Then the cells were stimulated with
5 ng/ml E. coli O111 LPS for further 20–24 h and TLR4 dependent NFkB activation was measured. (C–D) Human THP-1 macrophages were
preincubated for 3 h with purified lipid A, LA-core or LPS samples at the concentration indicated. Then the cells were stimulated with 1 ng/ml E. coli
O111 LPS for further 20 h and TNFa release was measured. Data were combined from n= 3 independent experiments, error bars indicated are
standard error of the mean.
doi:10.1371/journal.ppat.1002667.g007
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which can now be better explained based on the recent data
obtained with x-ray crystallography on the TLR4/MD-2/LPS
complex [21]. In this complex, phosphate groups of lipid A play a
crucial role. The 49 phosphate is thought to bind to positively
charged amino acids in the LRR of TLR4 (Arg264, Lys362) as well
as to MD-2 (Ser118 and Lys58) in a well-defined manner. This ionic
interaction seems to be critical for the ligand affinity of lipid A,
enabling formation of a hexameric (TLR4/MD-2/LPS)2 complex
necessary for signalling [21]. In the endotoxic lipid A, there is
another negatively charged group, 1 phosphate, which binds to
positively charged amino acids in the complex, especially in the
LRR of both TLR4 and the counter TLR4, called TLR4* (Lys388*
of TLR4*, Lys341, Lys362 of TLR4) and also to Arg122 of MD-2. In
contrast to the 49 phosphate which binds to two proteins (TLR4
and MD-2), the 1 phosphate is involved in binding to three
proteins in the complex (TLR4, TLR4*, and MD-2), suggesting
that this group might be even more important for the formation of
a stable hexameric (LPS/TLR4/MD-2)2 complex, as has been
reported [44]. We showed in this work that the lipid A of C.
canimorsus contains a P-Etn group at position 1, thus neutralizing
the negative charge of the 1 phosphate group. Therefore, we
propose that such modified phosphorylation may exert a
‘‘shielding effect’’ on the negative charge of the phosphate and,
hence, can explain why the lipid A of C. canimorsus is significantly
reduced in its endotoxic activity.
The lipid A structure of C. canimorsus is similar to that of the
closely genetically related E. meningoseptica with respect to the nature
and position of the acyl chains [30]. As reported for E. meningoseptica,
we also found some heterogeneity with respect to the nature of the
amino sugar at the non-reducing end in the lipid A backbone, but it
was significantly lower (2–5% in C. canimorsus compared to,30% in
E. meningoseptica) [30]. It has to be pointed out that this structural
modification has no influence on the biological activity of lipid A, as
it was shown for Campylobacter jejuni [45]. The Etn substitution at
position 1 of C. canimorsus lipid A is however not present in E.
meningoseptica [30]. One might thus expect that the lipid A of C.
canimorsus is less endotoxic than that of E. meningoseptica. To confirm
this suggestion a comparative study of lipid A of both species must
be carried out. Since the genus Capnocytophaga belongs to the
Bacteroidetes phylum [46], it is also not surprising that the structure of
lipid A from C. canimorsus shares some important traits involved in
specific TLR4 and MD-2 binding with the structure of Bacteroides
fragilis lipid A, which we determined earlier [47]. In particular, the
lipid A from both bacteria are (3+2) penta-acylated, lack the 49
phosphate and share iso-branched and linear acyl chains, including
i15:0, 16:0(3-OH), and i17:0(3-OH).
In agreement with its structural specifics, C. canimorsus lipid A
was shown here to exhibit a very low activity towards human
TLR4. C. canimorsus LPS and LA-core are 100- respectively 1000-
fold less active than E. coli O111 LPS towards human TLR4,
which reminds the activity of the closely related lipid A of E.
meningoseptica [30].
The data obtained with human TLR4 may seem to contradict
previous findings that whole heat killed C. canimorsus bacteria do
not stimulate human TLR4 [9]. However, in that early study, only
one concentration of bacterial lysate was used and compared to
purified E. coli LPS. From the results presented here, we know that
below a certain concentration, pure C. canimorsus LPS is weakly
active and the threshold concentration for endotoxicity is higher
than that of E. coli LPS. Thus, the C. canimorsus extracts used in
previous experiments may have contained LPS in insufficient
concentrations. In contrast to what was shown in Capnocytophaga
ochracea [48], C. canimorsus LPS and lipid A were found not to
antagonize the action of E. coli LPS on human TLR4.
The endotoxicity of the C. canimorsus LPS is probably reduced to
the level, which is tolerable in the dog’s mouth. We found C.
canimorsus LPS was even slightly less active towards canine than
human TLR4 in comparison to E. coli LPS. This reduced
inflammatory potential might benefit colonization of the dog’s
mouth. This reduced endotoxicity may probably as well explain
why the disease in humans often begins with mild symptoms
[2,6,49] and finally progresses to severe septicemia with shock and
intravascular coagulation. The higher threshold concentration for
endotoxicity of C. canimorsus LPS is in line with an initial immune
evasion. Nevertheless, at high concentrations it reaches an
activation comparable to the highly active E. coli LPS, which
might contribute substanitally to the septic shock observed in
patients suffering from C. canimorsus infections. Features of the LPS
could therefore account for initial evasion of C. canimorsus from the
host immune system, while the same LPS might later on induce
the endotoxic shock when present at higher concentration.
E. coli lipid A and O111 LPS exhibit a 10- to 100-fold difference
in endotoxicity and similar findings were made for P. gingivalis or
Proteus mirabilis [27,28]. The lipid A from E. meningoseptica also
shows only minor differences in TLR4 activation to its LPS [30].
In contrast, we found that C. canimorsus lipid A was around 20,000
fold less endotoxic than the LA-core, even higher when compared
on a molar basis, suggesting an important role of the core-
oligosaccharide in TLR4/MD-2 binding and activation. This
indicates the importance of the LPS core for TLR4 activation in
the case of C. canimorsus, which has a lipid A devoid of a net
negative charge. The C. canimorsus LPS core exhibits only one
unshielded negative charge, on the carboxylic oxygen of Kdo. The
negative charged carboxyl-group of Kdo in the C. canimorsus core
could therefore directly participate in TLR4 or MD-2 binding,
besides the reported inner core interactions with TLR4/MD-2
[21]. We found that the MD-2 binding ability of C. canimorsus lipid
A is strongly reduced compared to the LA-core and we could
exclude that changes in solubility were the reason for the
differences observed. This finding could explain the difference in
endotoxicity, as a lipid A not properly bound to MD-2 cannot
activate TLR4. It seems as if the C. canimorsus LPS core interacts
with CD14, LBP or MD-2 and thus enables the binding to MD-2.
By molecular modeling C. canimorsus lipid A was predicted to bind
MD-2 in a very similar way as E. coli lipid A and the calculated
binding energy for the two complexes was similar. As the energetic
state of the final complex would therefore be stable and favorable
in the case of C. canimorsus lipid A, we propose that the interactions
of the LPS core with MD-2 (or LBP/CD14) preceed the final lipid
A – MD-2 binding, rather than only stabilizing it. In our model,
summarized in Fig. 8, we suggest an intermediate state in which
the lipid A in the case of E. coli or the core in the case of C.
canimorsus form ionic interactions or hydrogen bonds with MD-2
allowing the lipid A – MD-2 complex to form at all. However, we
could not rule out a direct role of the LPS-core in binding to CD14
or LBP. To our knowledge, this is the first reported example of the
core-oligosaccharide changing dramatically the endotoxicity of
lipid A.
Materials and Methods
Chemicals
13:0(3-OH) was purchased from Larodan, Malmo¨, Sveden and
2,3 diamino-2,3-dideoxy-D-glucose (26HCl) from United States
Biochemical Corporation, Cleveland, OH, USA. All other
chemicals, solvents and reagents were of highest purity commer-
cially available. E. coli O111 LPS was purchased from Sigma-
Aldrich, lipidIVA from PeptaNova. E. coli F515 lipid A (hexa- and
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penta-acyl) was purified as described [50,51]. The analysis and
isolation of C. canimorsus LA-core will be described elsewhere
(Za¨hringer et al., manuscript in preparation). Purchased reagents
were resolved according to manufacturer’s instructions. Aliquots of
lipid IVA were kept at 280uC.
Isolation of LPS
C. canimorsus bacteria were harvested from 600 blood plates in
phosphate buffered saline (PBS) and washed with distilled water,
ethanol (300 ml) and acetone (300 ml), followed each time by
centrifugation at 18,0006 g for 30 min. Bacteria were air dried
and resuspended in PBS containing 1% phenol for killing and
storage in the deep freezer prior to LPS extraction. Cells were
washed with ethanol, acetone and diethyl ether (each 1 L) under
stirring (1 h, room temperature). After centrifugation cells were
dried on air to give 11.2 g. For the isolation of LPS, C. canimorsus 5
bacteria were extracted by phenol-water [52]. The LPS was
identified in the water phase, which also contained a large amount
of an unknown glucan polymer separated by repeated ultracen-
trifugation (100,0006g, 4 h, 4uC, 3 times). The glucan was further
analyzed (U. Za¨hringer and S. Ittig, manuscript in preparation)
and the LPS identified in the sediment. The crude LPS
preparation was further subjected to RNAse/DNAse treatment
(30 mg, Sigma) for 24 h at room temperature followed by
Proteinase K digestion (30 mg, 16 h, room temp.) and dialysis (2
days, 4uC), and lyophilization. The yield of enzyme-treated LPS
related to bacterial dry mass was 70 mg (0.6%).
Isolation of lipid A
Lipid A was prepared from C. canimorsus 5 (25 mg) LPS by
hydrolysis with 2% AcOH (4 ml) at 100uC until precipitation of
lipid A (2–8 h). The sediment was extracted three times with a
water-chloroform mixture (10 ml) and the organic phase was
concentrated to dryness under a stream of nitrogen to give
Figure 8. Proposed model for the implication of the LPS core or the 49 phosphate in enabling the binding to MD-2. Ionic interactions
or hydrogen bonds involving the 49 phosphate or the Kdo carboxy group in LPS lacking a 49 phosphate enable the binding of lipid A to either LBP
(1.), soluble CD14 (sCD14) (2.) or via an intermediate state to MD-2 (3.). Dependent on the type of lipid A bound to MD-2 this leads to TLR4
multimerization (4.), a downstream signaling cascade and finally release of proinflammatory cytokines (5.).
doi:10.1371/journal.ppat.1002667.g008
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17.7 mg of crude lipid A. The lipid A was purified by reversed
phase HPLC as described elsewhere [53] with the following
modifications: an Abimed-Gilson HPLC system equipped with a
Kromasil C18 column (5 mm, 100 A˚, 106250 mm, MZ-Analy-
sentechnik) was used. Crude lipid A samples (2–5 mg) were
suspended in 0.4 mL solvent A and the mixture was sonicated. A
0.1 M EDTA-sodium salt solution (100 ml, pH 7.0) was added
forming a bi-phasic mixture which was vortexed and injected
directly onto the column. Samples were eluted using a gradient
that consisted of methanol-chloroform-water (57:12:31, v/v/v)
with 10 mM NaOAc as mobile phase A and chloroform-methanol
(70.2:29.8, v/v) with 50 mM NaOAc as mobile phase B. The
initial solvent consisted of 2% B which was maintained for 20 min
after injection, followed by a linear three step gradient raising from
2 to 17% B (20–50 min), 17 to 27% B (50–85 min), and 27 to
100% B (85–165 min). The solvent was held at 100% B for 12 min
and re-equilibrated 10 min with 2% B and hold for additional
20 min before the next injection. The flow rate for preparative
runs was 2 ml/min (,80 bar) using a splitter (,1:35) between the
evaporative light-scattering detector (ELSD) and fraction collector.
The smaller part of the eluate was split to a Sedex model 75C
ELSD (S.E.D.E.R.E., France) equipped with a low-flow nebulizer.
The major part was collected by a fraction collector in 1 min
intervals (,2 ml each). Nitrogen (purity 99.996%) was used as gas
to nebulize the post column flow stream at 3.5 bar into the
detector at 50uC setting the photomultiplier gain to 9. The
detector signal was transferred to the Gilson HPLC Chemstation
(Trilution LC, version 2.1, Gilson) for detection and integration of
the ELSD signal.
GLC and GLC-MS analyses
Sugar and fatty acid derivatives were analysed by gas-liquid
chromatography (GLC) on a Hewlett-Packard HP 5890 Series
chromatograph equipped with a 30-m fused-silica SPB-5 column
(Supelco) using a temperature gradient 150uC (3 min)R320uC at
5u/min. GLC-MS was performed on a 5975 inert XL Mass
Selective Detector (Agilent Technologies) equipped with a 30-m
HP-5MS column (Hewlett-Packard) under the same chromato-
graphic conditions as in GLC.
ESI-MS analysis
Analyses of lipid A were performed in negative and positive ion
modes on a high resolution Fourier transform ion cyclotron
resonance mass spectrometer, FT ICR-MS (Apex Qe, Bruker
Daltonics, Billerica, MA, USA), equipped with a 7 T supercon-
ducting magnet and an Apollo dual electrospray-ionization (ESI)/
Matrix-assisted laser desorption ionization (MALDI) ion source.
Data were recorded in broadband mode with 512 K data
sampling rate. The mass scale was calibrated externally by using
compounds of known structure. For the negative ion mode
samples (ca. 10 ng/ml) were dissolved in a 50:50:0.001 (v/v/v)
mixture of 2-propanol/water/triethylamine (pH,8.5). For the
positive ion mode samples, a 50:50:0.03 (v/v/v) mixture of 2-
propanol/water/30 mM ammonium acetate adjusted with acetic
acid to pH 4.5 was used. The samples were sprayed at a flow rate
of 2 mL/min. The capillary entrance voltage was set to 3.8 kV and
the drying gas temperature to 150uC. The mass numbers given
refer to that of the monoisotopic ion peak. For MS/MS in the
positive ion-mode small amounts of TEN were added to the
sample preparation to obtain the [M+TEN+H]+ adduct ions [32]
which were selected for collision induced decay (CID) in the
collision cell infrared multiphoton dissociation (IRMPD) within
the ion cycIotron resonance (ICR) cell.
NMR spectroscopy
Lipid A samples (1–3 mg) were exchanged twice with deuter-
ated solvents [chloroform-d1/methanol-d4 1:1 (v/v), Deutero
GmbH, Kastellaun, Germany] and evaporated to dryness under
a stream of nitrogen. Samples were dissolved in 180 ml chloro-
form-d1/methanol-d4/D2O 40:10:1 (v/v/v, 99.96%) and analyzed
in 3 mm NMR tubes (Deutero). 1H-, 13C-, and 31P-NMR spectra
were recorded at 700.7 MHz (1H) on an Avance III spectrometer
equipped with a QXI-cryoprobe (Bruker, Germany) at 300 K.
Determination of NH-proton signals was performed in chloro-
form-d1(99.96%)/methanol/H2O 40:10:1 without exchange in
deuterated solvents. Chemical shifts were referenced to internal
chloroform (dH 7.260, dC 77.0).
31P NMR spectra were referenced
to external aq. 85% H3PO4 (dP 0.0). Bruker software Topspin 3.0
was used to acquire and process the NMR data. A mixing time of
100 ms and 200 ms was used in TOCSY and ROESY experi-
ments, respectively.
Compositional analyses
Quantification of GlcN, GalN (internal standard) and GlcN3N
by GLC and GLC-MS was done after strong acid hydrolysis of
0.5 mg lipid A in 4 M HCl (16 h, 100uC), followed by acetylation
(N-acetylation) in pyridine/acetic acid anhydride (10 min, 85uC),
reduction (NaBH4) and per-O-acetylation. The response factor of
the per-O-acetylated GlcNAc-ol, GalNAc-ol, and GlcNAc3NAc-ol
derivatives, necessary for the quantification of GlcN3N by GLC,
was determined in addition by external calibration with synthetic
reference sugars. Etn, GlcN, GlcN3N and their corresponding
phosphates (GlcN-P and Etn-P), were determined from the
hydrolysate by reversed phase HPLC using the Pico-tag method
and pre-column derivatization with phenylisothiocyanate accord-
ing to the supplier’s instructions (Waters, USA). Quantification of
total phosphate was carried out by the ascorbic acid method [54].
For analysis of ester- and amide-linked acyl chains, the lipid A was
isolated from LPS (1 mg) by mild acid hydrolysis (0.5 mL, 1%
AcOH, 100uC, 2 h), centrifuged and the lipid A sediment was
separated into two aliquots and lyophilized. Ester-linked acyl
chains were liberated from the first aliquot by treatment with
0.05 M NaOMe in water-free methanol (0.5 mL) at 37uC for 1 h.
The mixture was dried under a stream of nitrogen and acidified
(M HCl) prior to extraction with chloroform. The free acyl chains
were converted into methyl esters by treatment with diazomethane
and hydroxylated acyl chains were trimethylsilylated with N,O-
bis(trimethylsilyl)trifluoroacetamide for 4 h at 65uC [55]. The acyl
chain derivatives were quantified by GLC-MS using the corre-
sponding derivatives of 17:0 (50 mg) and 13:0(3-OH) (50 mg,
Larodan, Malmo¨, Sweden) as internal standards for the calibration
of the response factor of non-hydroxylated and hydroxylated acyl
chains, respectively. For analysis of total acyl chains, the second
aliquot was subjected to a combined acid/alkaline hydrolysis as
described [56]. Briefly, acyl chains were liberated from the lipid A
by strong acid hydrolysis (4 M HCl, 100uC, 21 h) and extracted
three times with water/chloroform (0.5 mL each). The organic
phase containing the N- and O-linked acyl chains was treated with
diazomethane, trimethylsilylated and quantified as described
above.
Bacterial strains and growth conditions
The strains used in this study are listed in Table S2. E. coli
strains were grown in LB broth at 37uC. C. canimorsus 5 [9] was
routinely grown on Heart Infusion Agar (HIA; Difco) supple-
mented with 5% sheep blood (Oxoid) for 2 days at 37uC in
presence of 5% CO2. Bacteria were harvested by scraping colonies
off the agar surface, washed and resuspended in PBS. Selective
C. canimorsus Lipid A Structure and Function
PLoS Pathogens | www.plospathogens.org 14 May 2012 | Volume 8 | Issue 5 | e1002667
agents were added at the following concentrations: erythromycin,
10 mg/ml; cefoxitin, 10 mg/ml; gentamicin, 20 mg/ml; ampicil-
lin, 100 mg/ml.
Human TLR4 activation assay
HEK293 stably expressing human TLR4, MD-2, CD14 and a
secreted NFkB dependent reporter were purchased from Invivo-
Gen (HEKBlue hTLR4). Growth conditions and endotoxicity
assay were as recommended by InvivoGen. Briefly, desired
amount of LPS or lipid A were placed in a total volume of 20 ml
(diluted in PBS) an added a flat-bottom 96-well plate (BD Falcon).
25000 HEKBlue hTLR4 cells in 180 ml were then added and the
plate was incubated for 20–24 h at 37uC and 5% CO2. If the
antagonistic activity of a compound on the action of E. coli O111
LPS was assayed, the compound was added in a total volume of
10 ml (diluted in PBS), 25000 HEKBlue hTLR4 cells in 180 ml
were added and the plate was incubated for 3 h at 37uC and 5%
CO2. Then the cells were stimulated with 5 ng/ml E. coli O111
LPS and the plate was incubated as above. Detection followed the
QUANTI-Blue protocol (InvivoGen). 20 ml of challenged cells
were incubated with 180 ml detection reagent (QUANTI-Blue,
InvivoGen). Plates were incubated at 37uC and 5% CO2 and
colour developed was measured at 655 nm using a spectropho-
tometer (BioRad). If needed the C. canimorsus lipid A stock solution
(1 mg/ml) was supplemented with 0.1% v/v TEN or 50% v/v
DMSO and sonicated for some minutes just before the assay. The
TEN containing lipid A stock solution was further diluted in a
0.1% TEN solution to keep the TEN concentration constant in all
samples. Due to the high concentration of DMSO used, this lipid
A stock solution was further diluted with PBS. As a control the
same amount of TEN or DMSO has been added to E. coli O111
LPS samples tested in the same assay. DMSO concentration in
50 mg/ml and 5 mg/ml were found to affect physiological test
conditions. These data have therefore been excluded from the
figure.
TNFa release by human THP-1 cells
Human THP-1 monocytes (ATCC TIB-202) were cultured as
recommended by the American Type Culture Collection (RPMI
1640 medium complemented with 10% v/v heat-inactivated fetal
bovine serum, 2 mM L-Glutamine). Monocytes were seeded at
1.56105 cells/ml in 24 well-plates (BD Falcon) in growth medium
containing 1027 M PMA (Sigma-Aldrich). For differentiation and
attachment the cells were incubated for 48 h at 37uC and 5% CO2
and then washed with growth medium and fresh PMA-free
medium was added. After further incubation for .1 h the cells
were challenged with the indicated amount of LPS or lipid A in a
total volume of 20 ml (diluted in PBS). After 20 h of incubation the
supernatants were harvested and immediately analyzed for TNFa
by an ELISA. ELISA was performed in accordance with the
manufacturers instructions (BD OptEIA). If an antagonist of E. coli
O111 LPS was assayed, the compound was added in a total
volume of 10 ml (diluted in PBS) to the THP-1 cells and the plates
were incubate for 3 h at 37uC and 5% CO2. Then the cells were
stimulated with 1 ng/ml E. coli O111 LPS and the plate was
incubated for 20 h at 37uC and 5% CO2.
IL-6 release by canine DH82 macrophages
Canine DH82 macrophages (ATCC CRL-10389) were cultured
in DMEM supplemented with 15% v/v heat-inactivated fetal
bovine serum, 2 mM L-Glutamine and non-essential amino acids
(Sigma-Aldrich) in a humidified incubator at 37uC and 5% CO2.
Cells were seeded at 16105 cells/ml in 24 well-plates (BD Falcon).
The cells were incubated for 24 h at 37uC and 5% CO2, before
being challenged with the indicated amount of LPS in a total
volume of 10 ml (diluted in PBS). After 14 h of incubation the
supernatants were harvested and immediately analyzed for content
of IL-6 by an ELISA. ELISA was performed in accordance with
the manufacturer’s instructions (R&D Systems, DY1609).
LPS biotinylation
Biotinylation of E. coli O111 LPS (Sigma-Aldrich) was
performed as described previously [57] using biotin-LC-hydrazide
(Pierce, Rockford, IL). To verify that the biotinylation did not
affect the functionality of the LPS, E. coli LPS-Biotin was assayed
for endotoxicity with the HEKBlue human TLR4 cell line (Data
not shown). Biotinylation reduced the endotoxic potential at low
concentrations, but only slightly at concentrations used in the MD-
2 binding assay.
Human MD-2 binding assay
MD-2 binding assays was performed as described [57,58].
HEK293 cells were transfected using Fugene6 (Roche, 3:2
protocol) with a plasmid (kind gift of K. Miyake and C.
Kirschning) encoding human MD-2 with a C-terminal Flag-His-
tag (pEFBOS-hMD2-Flag-His) [15]. The medium was exchanged
3–8 h post transfection with fresh growth medium. The cells were
incubated for 48 h and the supernatant was harvested and pooled.
Fresh FCS was added to the hMD-2 supernatant (7.5% v/v) as a
source of CD14 and LBP. For each binding reaction, 4 ml of
hMD-2 supernatant were combined with 250 ng, 500 ng, 1 mg,
2 mg, 5 mg or 10 mg of the competitor, incubated at room
temperature and gently rocked for 30 min. If needed the C.
canimorsus lipid A stock solution (1 mg/ml) was supplemented with
0.1% v/v TEN or 50% v/v DMSO and sonicated for some
minutes just before addition to the hMD-2 supernatant. 1 mg of
biotinylated E. coli O111 LPS was added and the supernatant was
further incubated for 3–4 h at room temperature. Biotinylated
LPS–hMD-2 complexes or single biotinylated LPS were captured
by addition of 120 ml (total volume) streptavidin-agarose beads
(IBA) per sample. The beads were previously prepared by washing
them three times with a buffer (100 mM Tris, 150 mM NaCl,
pH 8.0). For binding, the supernatants containing the beads were
incubated overnight on a rotator at 4uC. Agarose beads were
pelleted by centrifuging for 30 s at 50006 g and 4uC and washed
three times with PBS containing 0.5% Tween 20. The beads were
finally resuspended in 60 ml SDS-loading dye (without dithiothre-
itol) and boiled for 5 min at 95uC. The protein content in the
sample was analyzed by non-reducing, denaturing 4–12% Tris-
glycine Polyacrylamide gels (Invitrogen) or 4–15% Tris-glycine
Polyacrylamide gels (BioRad) and then transferred to polyvinyli-
dene fluorid (PVDF) membrane (ImmobilonP, Millipore). Mem-
branes were probed using monoclonal anti-Flag antibody (Sigma-
Aldrich) according to the manufacturer’s instructions using ECL-
Plus reagent (GE Healthcare).
Genome annotation
Blast-p search tool [59] against the C. canimorsus 5 genome [5]
was used. Search sequences were obtained from the National
Center for Biotechnology Information. All available Bacteroidetes-
group sequences were used as search if available, but standard E.
coli sequences have always been included. The highest scoring
subjects over all the searches have been annotated as correspond-
ing enzymes. Difficulties in annotation were only observed for
lpxE. lpxE search was based on lpxF and/or lpxE sequences from P.
gingivalis [38], F. novicida [60], R. etli [40], H. pylori [37,41] and on
all available Bacteroidetes-group pgpB sequences. Three lpxE/F
candidates have been found in the C. canimorsus 5 genome (Ccan
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16960, Ccan 14540 and Ccan 6070). All candidates have been
deleted and only deletion of Ccan 16960 affected endotoxicity (data
not shown). Since this gene is encoded in an operon with the
predicted eptA and since the same operon structure (lpxE-eptA) has
been identified in H. pylori [37] Ccan16960 was annotated as lpxE.
Molecular modeling
The MD-2 - E. coli LPS complex (PDB code 3FXI) [21] was
used to construct models for the MD-2 - E. coli lipid A and for the
MD-2 – C. canimorsus Lipid A. The modeling of the lipid A
moieties was performed using the VMD [61] program and the
leap module of the AMBER11 [62] suite of programs. To
investigate the time-dependent properties of the two MD-2 – lipid
A complexes, the constructed systems were subjected to
molecular dynamics simulations [63] in the framework of a
classical molecular mechanics [64] (MM) description. MM
parameters from the Glycam06 [65,66] force field were adapted
to describe the acyl chains and the sugar moieties, while the
Amber99SB [67,68] force field was employed for the MD-2
protein. Advanced methods based on quantum chemistry were
employed to obtain the missing parameters of the ester linkages
and hydroxyl groups on the acyl chain C2 atoms, the branching
at the bottom of the C. canimorsus acyls, the phosphate/P-Etn
groups and the GlcN3N9 moiety. Bonding parameters were
obtained by performing relaxed potential energy scans [69]
(bonds, angles, dihedrals), while charges were calculated on the
optimized geometries of selected capped fragments. All the scan
and geometry optimizations were conducted at the RI-MP2/
def2-TZVP [70,71,72] level using the COBRAMM [73] suite of
programs efficiently linking the ORCA2.8 [74] (wave-function
calculation) and the GAUSSIAN09 [75] (optimization/scan
driver) programs. Charges were calculated according to the
RESP procedure at the HF/6-31G*//MP2/def2-TZVP. Both
MD-2 – lipid A complexes were embedded in a
6.566.566.5 nm3 box of TIP3P [76] water molecules and the
appropriate number of Na+ and Cl2 ions were added to
neutralize the systems charge. The systems were relaxed
(conjugate gradient geometry optimization) to remove clashes
before stating molecular dynamics simulations. The systems were
both heated to 300 K in the NVT (constant particle number,
volume, temperature) ensemble for 500 ps and then equilibrated
in the NPT (constant particle number, pressure, temperature)
until relevant structural parameters (density, RMSD on the
protein Ca) were found to be stable (1 ns). Statistics were then
performed on trajectories collected from 10 ns long simulations of
the equilibrated systems. All molecular dynamics calculations
were performed with the sander module of the AMBER11
package; bonds involving H atoms were constrained using the
SHAKE algorithm [77] to allow for using a time step of 2 fs.
Pressure was controlled via a simple Berendsen weak coupling
approach [78], while a Langevin thermostat (collision frequency
set to 3 ps21) was used to enforce the desired temperature.
Molecular dynamics trajectories were analyzed using the VMD
software, the ptraj module of the AMBER11 suite and the ProDy
[79] package. A set of 300 snapshots of the equilibrated
trajectories was subjected to further analysis to quantify the
binding energy between MD-2 and each of the two lipid A
moieties. Both the MM-PBSA and MM-GBSA approaches [80]
were used to calculate the MD-2 – lipid A binding energy, while a
full interaction energy decomposition [81,82] was performed
using the cheaper MM-GBSA method; the MMPBSA.MPI
module of AMBER11 was used to perform the binding free
energy calculations, while a locally developed software was used
to process, analyze and plot the results.
Western-blot quantification
Quantification was performed using MultiGauge software
(Fujifilm).
Supporting Information
Figure S1 HPLC elution profile of the lipid A from C. canimorsus
5. HPLC elution profiles of the semi-preparative fractionation of
the lipid A from wild type C. canimorsus 5 (2.1 mg). Peak Nr. 2
(124.3 min) represents the intact lipid A and peak Nr. 5
(131.9 min) the 1-dephosphorylated lipid A (LA without P-Etn)
as determined by ESI MS. The other peaks belong to lipid A with
slightly modified fatty acids composition (Table 2). For HPLC
conditions see Materials and Methods.
(TIF)
Figure S2 Negative mode ESI mass spectrum of lipid A from C.
canimorsus indicating heterogeneity in the length of fatty acids (-
CH2-, Dm/z= 14 u) as also shown in Table 2.
(TIF)
Figure S3 CID-MS/MS (positive mode) of lipid A from C.
canimorsus showing the B-fragment (non-reducing end) obtained
from the parent ion [M+TEN+H]+ [m/z 1819.3]. The abundant
B-fragment ion is consistent with a GlcN3N carrying two primary
fatty acids [16:0(3-OH) and i17:0(3-OH)] in amide linkage and
one (i15:0) in ester linkage forming an acyloxyacyl residue [i17:0(3-
O(i15:0)] and proves the hybrid backbone (GlcN3N9-GlcN) to be
the major one (.95%) and the distribution of the fatty acids to be
3+2.
(TIF)
Figure S4 1H,31P-HMQC (top) and 1H,31P-HMQC-TOCSY
(bottom) spectra (700 MHz) of lipid A in chloroform-methanol-
water (20:10:1, v/v/v) at 27uC. The 31P NMR spectrum and the
corresponding part of the 1H NMR spectrum are displayed along
the F1 and F2 axes, respectively. Numerals refer to atoms in sugar
and acyl chain residues denoted by letters as shown in
Supplementary Table 1 and Fig. S2.
(TIF)
Figure S5 Activation of human TLR2 with C. canimorsus (Cc) or
E. coli lipid A (LA) or LA-core preparations. Indicated concentra-
tions of purified lipid A or LA-core samples were assayed for
TLR2 dependent NFkB activation with HEKBlue human TLR2
cells. The triacylated lipopetide Pam3CSK4 was used a positive
control. Data were combined from n = 3 independent experi-
ments, error bars indicated are standard error of the mean.
(TIF)
Table S1 1H (700 MHz) and 13C (176.2 MHz) NMR data of
the lipid A from C. canimorsus (CDCl3/MeOD/D2O, 40:10:1, v/v/
v). Chemical shifts are referenced to internal CDCl3 (dH 7.26, dC
77.0) at 27uC. For the assignment of the individual acyl chains see
Fig. 2.
(XLS)
Table S2 Bacterial strains used in this study.
(DOC)
Text S1 Supplementary methods.
(DOC)
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